Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00386893
NCT00386893
Withdrawn
Phase 4

Influence of Escitalopram on Somatosensory Processing in Patients With Major Depression

Ludwig-Maximilians - University of Munich1 site in 1 countryOctober 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDepression

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Depression
Sponsor
Ludwig-Maximilians - University of Munich
Locations
1
Primary Endpoint
changes in evoked potentials/functional MRI from baseline to week 4
Status
Withdrawn
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Aim of this study is to investigate neuronal differences (EEG/evoked potentials; functional MRI) between patients with major depression and healthy controls concerning brain activity after acute pain as well as changes of pain related brain activity during treatment with escitalopram.

Registry
clinicaltrials.gov
Start Date
October 2006
End Date
December 2011
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Oliver Pogarell

Investigator

Ludwig-Maximilians - University of Munich

Eligibility Criteria

Inclusion Criteria

  • •Psychiatric in or outpatients with acute depressive episode
  • •Indication for pharmacological treatment

Exclusion Criteria

  • •Acute suicidal tendency
  • •Neurological or severe somatic disorders
  • •Women during pregnancy or lactation

Outcomes

Primary Outcomes

changes in evoked potentials/functional MRI from baseline to week 4

Time Frame: two assessments, at baseline and week 4

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 4
Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving EscitalopramDepression
NCT00183677Massachusetts General Hospital97
Completed
Not Applicable
Specific Effects of Escitalopram on Neuroendocrine ResponseHealthy
NCT00150527Queen's University8
Completed
Not Applicable
Brain Activity Changes Measured by EEG and fMRI on Healthy Volunteers After Complex Somatosensory StimulationHealthy Volunteers
NCT01079689Charite University, Berlin, Germany20
Unknown
Phase 4
Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive DisorderMajor Depressive Disorder
NCT01997580Seoul National University Bundang Hospital600
Active, not recruiting
Phase 1
Effekte von Escitalopram auf Aufmerksamkeit und kognitive Funktionen bei gesunden Probanden - Escitalopram
EUCTR2005-001991-11-DEniversity of Aachen100